# ADR 507 — Enterprise Biotechnology Digital Health Intelligence Platform (P217-H)

## Status

Accepted

## Context

P217-G established biological simulation and digital twins. P217-H defines Digital Health Intelligence: healthcare AI, predictive medicine, patient intelligence, clinical decision support, health digital twins and responsible health-AI governance — before Precision Medicine (P217-I).

## Decision

1. SoR remains `biotechnology` / `CAP-PLT-BIO-001` for health *intelligence* catalogs — never EMR/LIMS/pharmacy SoR.
2. Fabric: `meos_digital_health_intelligence_fabric`.
3. API: `/api/v1/biotechnology/digital-health*`.
4. Six digital-health layers; healthcare AI components; predictive medicine + patient intelligence catalogs.
5. All inference via P214-Z ACL only — `no_module_local_llm`.
6. Clinical recommendations require human physician validation — never autonomous clinical action without physician.
7. Never replace Core, AI, Quantum, Robotics, hospital EMR, LIMS, pharmacy, prior P217 fabrics.
8. Foundation for P217-I.

## Consequences

Positive: governed health-intelligence layer for precision medicine and clinical research phases.  
Negative: clinical safety / explainability catalogs must stay aligned as personalization deepens.

## Alternatives rejected

- Sibling `digital_health` BC owning EMR records.
- Module-local LLM or autonomous clinical actuation.
- Merging hospital/clinic SoR into biotechnology.

## Related

Law: `ENTERPRISE_BIOTECHNOLOGY_DIGITAL_HEALTH.md` · Prior: ADR 499–506 · Next: P217-I
